APA (7th ed.) Citation

Shore, N., Nguyen, Kang, B., Sawhney, A., Byrne, C., Tang, J., . . . Patel, J. (2026). Real-world clinical outcomes and economic burden of discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer. International Journal of Clinical Oncology, 31(8), 1451. https://doi.org/10.1007/s10147-026-03102-2

Chicago Style (17th ed.) Citation

Shore, Neal, Nguyen, Barinder Kang, Amrita Sawhney, Clare Byrne, Jackson Tang, Magdaliz Gorritz, Chi-Chang Chen, and Jeetvan Patel. "Real-world Clinical Outcomes and Economic Burden of Discontinuation of Taxane Therapy Among Patients with Metastatic Castration-resistant Prostate Cancer." International Journal of Clinical Oncology 31, no. 8 (2026): 1451. https://doi.org/10.1007/s10147-026-03102-2.

MLA (9th ed.) Citation

Shore, Neal, et al. "Real-world Clinical Outcomes and Economic Burden of Discontinuation of Taxane Therapy Among Patients with Metastatic Castration-resistant Prostate Cancer." International Journal of Clinical Oncology, vol. 31, no. 8, 2026, p. 1451, https://doi.org/10.1007/s10147-026-03102-2.